Sanofi India, the pharma company announced results for the quarter ending March 31, 2018.
The company reported revenue from operations of Rs 617.7 crores for a period of January-March 2018 as against Rs 552.9 crores during January-March 2017, up by 11.72%.
The Net Profit of the company stood at Rs 82.5 crore for the January-March 2018 quarter as against Rs 60.0 crore for January-March 2017 quarter, up by 37.5%.
Sanofi India's Board also approved the appointment of Mr. Charles Billard as Chief Financial Officer and Key Managerial Personnel with effect from July 1, 2018.
Mr. Lionel Guerin, the current Chief Financial Officer, and Whole Time Director will take up a new role within Sanofi group and will, therefore, step down as the Chief Financial Officer and Whole Time Director of the Company with effect from the close of the day on June 30, 2018. He will, however, continue to be engaged with the Company as a Non-Executive Director. He will cease to be the Key Managerial Personnel of the Company.
The stocks of Sanofi India Ltd were trading at Rs 4,881.30 per piece, up by Rs 46.90
in BSE at 3:30 pm (IST).